Workflow
Exponent(EXPO)
icon
Search documents
Exponent(EXPO) - 2020 Q4 - Earnings Call Transcript
2021-02-05 01:30
Exponent, Inc. (NASDAQ:EXPO) Q4 2020 Earnings Conference Call February 4, 2021 4:30 PM ET Company Participants Whitney Kukulka - IR Dr. Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Tobey Sommer - Truist Andrew Nicholas - William Blair Sam England - Berenberg Marc Riddick - Sidoti Operator Good day, and welcome to the Exponent Fourth Quarter and Fiscal Year 2020 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conf ...
Exponent(EXPO) - 2020 Q3 - Quarterly Report
2020-11-06 21:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) Delaware 77-0218904 (State or ...
Exponent(EXPO) - 2020 Q3 - Earnings Call Transcript
2020-10-31 01:35
Exponent, Inc. (NASDAQ:EXPO) Q3 2020 Earnings Conference Call October 29, 2020 4:30 PM ET Company Participants Whitney Kukulka - IR Catherine Corrigan - President & CEO Rich Schlenker - EVP & CFO Conference Call Participants Sam England - Berenberg Bank Alexis Huseby - D.A. Davidson & Company Andrew Nicholas - William Blair Tobey Sommer - Truist Financial Operator Good day, and welcome to Exponent's Third Quarter Earnings Call. [Operator Instructions] At this time, I would like to turn the conference over t ...
Exponent(EXPO) - 2020 Q2 - Quarterly Report
2020-08-07 23:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or ot ...
Exponent(EXPO) - 2020 Q1 - Quarterly Report
2020-05-08 20:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or o ...
Exponent(EXPO) - 2020 Q1 - Earnings Call Transcript
2020-05-01 02:11
Exponent, Inc. (NASDAQ:EXPO) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corrigan – President and Chief Executive Officer Rich Schlenker – Executive Vice President and Chief Financial Officer Conference Call Participants Tobey Sommer – SunTrust Trevor Romeo – William Blair Marc Riddick – Sidoti Alexis Huseby – D.A. Davidson Sam England – Berenberg Operator Good day and welcome to the Exponent’s First Quarter of Fiscal Year 20 ...
Exponent(EXPO) - 2020 Q4 - Annual Report
2020-02-28 21:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2020. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________. Commission File Number 0-18655 EXPONENT, INC. | --- | --- | --- | --- | --- | |------------------------------------------------------------------------- ...
Exponent(EXPO) - 2019 Q4 - Earnings Call Transcript
2020-02-07 04:02
Exponent, Inc. (NASDAQ:EXPO) Q4 2019 Results Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants Whitney Kukulka - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Drew Kootman - Cantor Fitzgerald Alexis Huseby - D.A. Davidson & Company Jasper Bibb - SunTrust Andrew Nicholas - William Blair Marc Riddick - Sidoti Operator Good day. And welcome to the Exponent Fourth Quarter and Fiscal Year 2019 E ...
Exponent(EXPO) - 2019 Q3 - Quarterly Report
2019-11-01 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State ...
Exponent(EXPO) - 2019 Q3 - Earnings Call Transcript
2019-10-18 01:01
Exponent, Inc. (NASDAQ:EXPO) Q3 2019 Earnings Conference Call October 17, 2019 4:30 PM ET Company Participants Whitney Kukulka – Investor Relations Catherine Corrigan – President and Chief Executive Officer Rich Schlenker – Executive Vice President and Chief Financial Officer Conference Call Participants Joseph Foresi – Cantor Fitzgerald Alexis Huseby – D.A. Davidson Andrew Nicholas – William Blair Tobey Sommer – SunTrust Sam England – Berenberg Operator Good day and welcome to the Exponent Third Quarter of ...